These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4037132)

  • 1. Urinary free cortisol levels and dexamethasone suppression testing in organic affective disorder associated with hyperthyroidism.
    Kathol RG; Delahunt JW; Cooke R
    Am J Psychiatry; 1985 Oct; 142(10):1193-5. PubMed ID: 4037132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in organic affective syndrome.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1984 Nov; 141(11):1465-7. PubMed ID: 6496794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL; Nemeroff CB
    J Psychiatr Res; 1987; 21(2):185-94. PubMed ID: 3585807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M; De Ruyter M; Suy E
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients.
    Thase ME; Dubé S; Bowler K; Howland RH; Myers JE; Friedman E; Jarrett DB
    Am J Psychiatry; 1996 Jul; 153(7):886-91. PubMed ID: 8659610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding.
    Kathol RG
    J Affect Disord; 1985; 8(2):137-45. PubMed ID: 3157722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder.
    Krystal A; Krishnan KR; Raitiere M; Poland R; Ritchie JC; Dunnick NR; Hanada K; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):34-43. PubMed ID: 1967010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test: interaction of diagnosis, sex, and age in psychiatric inpatients.
    Nelson WH; Khan A; Orr WW; Tamragouri RN
    Biol Psychiatry; 1984 Sep; 19(9):1293-304. PubMed ID: 6498252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects.
    Amsterdam JD; Winokur A; Caroff SN; Conn J
    Am J Psychiatry; 1982 Mar; 139(3):287-91. PubMed ID: 7058940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unreliability of TRH test but not dexamethasone suppression test as a marker of depression in chronic vasculopathic patients.
    Marchesi C; Silvestrini C; Ponari O; Volpi R; Chiodera P; Coiro V
    Biol Psychiatry; 1996 Oct; 40(7):637-41. PubMed ID: 8886297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak amplitude and frequency of urinary free cortisol excretion in patients with a history of major depressive disorder.
    Kathol RG; Gehris T
    Chronobiol Int; 1986; 3(4):281-7. PubMed ID: 3677209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma dexamethasone levels in children given the dexamethasone suppression test.
    Naylor MW; Greden JF; Alessi NE
    Biol Psychiatry; 1990 Mar; 27(6):592-600. PubMed ID: 2322618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.